Cita APA (7a ed.)
Rimini, M., Loi, E., Rizzato, M. D., Pressiani, T., Vivaldi, C., Gusmaroli, E., . . . Salani, F. (2024). Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine Plus Durvalumab. Targeted Oncology, 19(2), 223-236.
Cita Chicago Style (17a ed.)
Rimini, Margherita, et al. "Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine Plus Durvalumab." Targeted Oncology 19, no. 2 (2024): 223-236.
Cita MLA (9a ed.)
Rimini, Margherita, et al. "Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine Plus Durvalumab." Targeted Oncology, vol. 19, no. 2, 2024, pp. 223-236.
Precaución: Estas citas no son 100% exactas.